gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · NAIIHealthcarePharmaceuticals

Natural Alternatives International Inc. (NAII)

$1.06−0.93%
Close Nov 3, 2026 · split-adjusted
Nov 2, 2026$1.07▼ 60.81% in range
Nov 3, 2025Low $1.07 · High $4.83Nov 2, 2026
What changed · written from our data
As of Nov 3, 2026

Natural Alternatives International closed at $1.06 on Nov 3, down 0.93%, within 0.0% of its 52-week closing low. Volume of 5.1K shares was 0.20× its 20-day average (below normal).

Split-adjusted performance: -25.9% over one month, -59.4% over six months, -61.1% over one year.

In the quarter ended Jun 30, 2026, revenue was $34.51M, up 1.9% from a year earlier, with a net margin of -39.2%.

Short interest was 4.3K shares at the Oct 15 settlement, down 37.4% from the prior report (0.1% of float, 1.0 days to cover).

Market cap$6.6M6.3M shares
Revenue · quarter$34.5M+1.9% YoY
Diluted EPS$-2.23—
P/E · TTM—P/S 0.0×
Net margin-39.2%Gross 5.0%
Dividend yieldNone
52-week range1.06 – 4.83−78.1% from high
Volume5.1K0.20× 20-day avg
Volatility · 60d59.1%Annualised
Short % of float0.1%1.0 days to cover
Net cash-$10.6MCash $7.4M
Next earnings—Not scheduled
Split-adjusted performance
1W −6.2%1M −25.9%3M −53.1%6M −59.4%YTD −70.4%1Y −61.1%3Y −82.4%5Y −91.8%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum18
Revenue growth43
Net margin49
Value (low P/E)—
Size11

Industry medians: 6-month return −26.5%, revenue growth +6.4%, net margin −38.1%, P/E 16.4×.

Short interest

Details →
Shares short4.3K−37.4% vs prior
Days to cover1.0Settled Oct 15
% of float0.1%
Short vol. 10d17.3%of daily volume

Closest peers by size in Pharmaceuticals

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
NAIINatural Alternatives International$1.06−0.93%−59.4%+1.9%−39.2%—$6.6M
CNSPCNS Pharmaceuticals$4.55+3.64%−36.4%———$6.6MCompare
XCURExicure$1.01−0.98%−70.3%———$6.6MCompare
ENVBEnveric Biosciences$1.50+3.45%−56.9%———$6.7MCompare
APREAprea Therapeutics$0.5150+4.89%−38.9%−100.0%——$6.5MCompare
FBLGFibroBiologics$0.9900+7.60%−25.6%———$7.0MCompare
ALZNAlzamend Neuro$1.46+16.80%+36.4%———$7.0MCompare
ENSCEnsysce Biosciences$0.3777−1.15%−5.6%−15.1%−220.8%—$7.3MCompare
VTGNVistagen Therapeutics$0.1680+0.30%−72.0%+504.9%−882.8%—$7.5MCompare

News about Natural Alternatives International

All news →
Natural Alternatives Q4 Loss Widens Y/Y on Margin PressureZacks Investment Research · Sep 29, 2026▼ Negative

Quick answers

What does Natural Alternatives International do?
Natural Alternatives International Inc is formulator, manufacturer and marketer of nutritional supplements. Its comprehensive strategic partnerships with its customers allow to offer a wide range of nutritional products and services to such customers including scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review, and international product registration assistance.
What is NAII's market cap?
$6.64M, based on the Nov 3 close of $1.06.
Does Natural Alternatives International pay a dividend?
No regular cash dividend has been paid in the last year.
How much of NAII is sold short?
4.3K shares, 0.1% of float, as of Oct 15, 2026.
What sector is NAII in?
Healthcare, in the Pharmaceuticals industry.

About Natural Alternatives International

Natural Alternatives International Inc is formulator, manufacturer and marketer of nutritional supplements. Its comprehensive strategic partnerships with its customers allow to offer a wide range of nutritional products and services to such customers including scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review, and international product registration assistance. It has two segments Private-label contract manufacturing, and Patent and trademark licensing. Majority of revenue comes from Private-label contract manufacturing. Majority of revenue comes from United States.

HQ: Carlsbad, CA230 employeesListed Sep 1, 1987nai-online.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology